Topics
“Your gut is leaking.”
It is difficult to design a more persuasive health message.
The phrase is visual.
It sounds mechanical.
It offers one explanation for many unrelated symptoms.
Fatigue.
Brain fog.
Bloating.
Acne.
Joint pain.
Anxiety.
Weight gain.
Autoimmune disease.
Food intolerance.
Hormonal problems.
The model is usually presented like this:
Then comes the solution:
remove gluten,
remove lectins,
remove seed oils,
take probiotics,
take glutamine,
drink bone broth,
buy a stool test,
measure zonulin,
“heal the gut”.
The reason this narrative is difficult to dismiss is that the first part is real.
The intestine really is a barrier.
Its permeability really changes.
Barrier dysfunction really occurs in important diseases.
The mistake comes later, when a property of one biological system becomes a universal diagnosis.
The intestinal barrier is real, but it is not a brick wall
The gastrointestinal tract has to solve a difficult optimisation problem.
It must absorb nutrients and water while limiting the passage of pathogens, antigens and potentially harmful luminal material.
If the barrier were completely impermeable, digestion and absorption would fail.
If it were indiscriminately permeable, host defence would fail.
So healthy intestinal physiology requires selective permeability.
The barrier includes much more than a single layer of cells.
It contains:
- mucus;
- epithelial cells;
- tight-junction and adherens-junction proteins;
- immune cells;
- antimicrobial peptides;
- secretory immunoglobulins;
- vascular and lymphatic components;
- interactions with the microbiota.
A useful abstraction is
where
- $P$ is effective permeability,
- $J$ represents intercellular junctions,
- $M$ mucus,
- $E$ epithelial integrity,
- $I$ immune state,
- $\mu$ microbial interactions,
- $S$ external stressors,
- $t$ time.
There is no single anatomical “seal” that is either open or closed.
Source:
Increased permeability is not imaginary
This is where careless debunking goes wrong.
Intestinal permeability can increase in real human disease.
It is well documented in conditions including coeliac disease and inflammatory bowel disease.
In coeliac disease, gluten exposure triggers an immune-mediated enteropathy in genetically susceptible people. Increased permeability can accompany the mucosal injury, and older human studies showed that permeability measurements improve after initiation of a gluten-free diet.
In inflammatory bowel disease, disruption of epithelial integrity, immune activation and altered barrier function are active areas of pathophysiological research.
This is not wellness terminology.
It is gastroenterology.
Sources:
- Cummins et al., coeliac disease and intestinal permeability
- Rath, Atreya & Neurath, 2023, intestinal permeability and IBD
- Intestinal Barrier Dysfunction in Inflammatory Bowel Disease, 2023
The problem is the word “syndrome”
A physiological phenomenon does not automatically define a clinical syndrome.
A syndrome usually requires some reproducible relationship between:
- symptoms or signs;
- diagnostic criteria;
- measurable abnormalities;
- exclusion of alternatives;
- clinically meaningful prognosis or treatment response.
“Leaky gut syndrome” as used online often has none of those constraints.
The diagnosis may be inferred from almost any non-specific complaint.
That creates a model with extremely poor falsifiability.
If someone is tired, the gut may be leaking.
If someone is bloated, the gut may be leaking.
If someone is anxious, the gut may be leaking.
If someone has acne, the gut may be leaking.
If laboratory testing is normal, the leak is said to be subtle.
If symptoms improve after changing diet, that is taken as confirmation.
If symptoms do not improve, the person is told the gut has not healed yet.
A hypothesis that can explain every result risks explaining nothing.
“All disease begins in the gut” is not a scientific model
This phrase is often attributed to Hippocrates and used as if it were a modern causal theorem.
Even if one ignores the historical attribution problem, the biology is obviously more complicated.
Some diseases have strong gastrointestinal components.
Some are influenced by microbial or immune interactions involving the gut.
Others do not plausibly originate there in any useful sense.
A causal model for human disease looks more like
where genetics, environment, age, exposures, behaviour, infection, metabolism and time all interact.
Replacing that with
is not holistic medicine.
It is dimensionality reduction performed without checking the loss function.
Myth 1: a “leaky gut” diagnosis explains non-specific symptoms
Fatigue, bloating, headache, mood disturbance and skin symptoms are real.
They are also non-specific.
A non-specific symptom has many possible causes.
The presence of fatigue therefore provides little information about intestinal permeability unless additional evidence changes the prior probability.
Using Bayes' rule schematically,
where $L$ represents clinically relevant increased permeability and $F$ fatigue.
If fatigue occurs in many states unrelated to intestinal permeability, then $P(F)$ is large and the symptom alone has poor diagnostic specificity.
The internet often reverses this logic.
A common symptom is treated as if it were a specific biomarker.
It is not.
Myth 2: a blood zonulin test proves your gut is leaking
This is one of the strongest examples of how a biomarker acquires more authority than its assay deserves.
Zonulin became popular because it was proposed as a regulator of intestinal tight junctions and therefore appeared to provide a convenient blood marker for barrier permeability.
Commercial tests followed.
The problem is analytical.
Several studies have reported that widely used commercial “zonulin” ELISA kits do not appear to measure pre-haptoglobin-2, the protein originally identified as zonulin.
One investigation using immunoprecipitation and mass spectrometry found that commercial assays were detecting other proteins, including complement-related proteins, rather than the presumed target.
Another found that a widely used ELISA did not detect pre-haptoglobin-2 and may instead recognise properdin or related proteins.
This matters enormously.
Suppose a test reports value $Z^*$.
If
then clinical interpretation cannot simply proceed as though the assay measured the intended molecule.
Sources:
- Ajamian et al., 2019, serum zonulin may not be what it seems
- Scheffler et al., 2018, commercial ELISA does not detect pre-haptoglobin-2
Even the commercial “zonulin” value may not correlate with physiological permeability
The problem is not merely molecular identity.
In first-degree relatives of people with Crohn's disease, serum “zonulin” measured with a commercial kit failed to correlate with a physiological lactulose-mannitol permeability measure.
A study in healthy adults similarly concluded that serum zonulin measured by commercial ELISA may not be a reliable marker of small-intestinal permeability.
So a result can have at least two layers of uncertainty:
The number on a laboratory report may be precise to two decimal places.
That does not make the inference precise.
Sources:
How intestinal permeability is actually measured
There is no perfect single test.
One traditional approach uses orally administered probe molecules.
Different sugars have different absorption properties.
Urinary recovery can then be compared.
For example, the lactulose-mannitol ratio has been used as an indirect measure of small-intestinal permeability.
Conceptually,
But even this measure depends on:
- intestinal transit;
- gastric emptying;
- renal function;
- urine collection;
- probe dose;
- intestinal surface area;
- timing.
Other approaches use tissue measurements, endoscopic biopsies, electrical resistance, circulating markers or combinations of biomarkers.
A 2025 review of intestinal-permeability biomarkers described numerous candidates, including sugar probes, intestinal fatty-acid binding protein, D-lactate, citrulline, endotoxin-related measures and zonulin.
That diversity itself tells us something important:
there is no single universally accepted blood test that converts “gut leakiness” into one definitive number.
Source:
Myth 3: increased permeability is always pathological
Not necessarily.
Permeability is dynamic.
Acute exercise is a good example.
A systematic review and meta-analysis of healthy populations found that a single bout of exercise, particularly strenuous exercise, can increase indirect markers of intestinal damage and permeability.
Heat stress, reduced splanchnic blood flow and exercise intensity can contribute.
Does that mean exercise causes “leaky gut syndrome”?
No.
It means a physiological stressor can temporarily alter barrier function.
Pregnancy, non-steroidal anti-inflammatory drugs and other stress states can also influence permeability.
The existence of a transient change does not establish chronic disease.
This distinction is crucial:
Sources:
Myth 4: if permeability is abnormal, fixing permeability will cure the disease
This is a classic reversal of causality.
Suppose disease $D$ is associated with barrier abnormality $P$.
Several causal structures are possible:
or
or
or some feedback system:
Association alone does not identify the graph.
Camilleri's human review makes this point directly: inflammatory and ulcerative intestinal diseases can result in increased permeability, but it remains unproven in many contexts that merely normalising barrier function will resolve the clinical disease.
This is a broader lesson.
A biomarker can participate in disease without being an independently sufficient treatment target.
LDL lowering has causal trial evidence for cardiovascular outcomes.
A “gut permeability score” does not automatically have the same status.
Source:
Myth 5: gluten makes everyone's gut leak
This claim often comes from legitimate coeliac-disease biology stretched beyond the population in which it was demonstrated.
For people with coeliac disease, gluten is a defined pathological trigger.
Removing gluten is treatment.
That does not imply that everyone should avoid gluten to preserve barrier integrity.
Healthy people do not become coeliac simply because they eat wheat.
There are also people with wheat allergy and people reporting non-coeliac wheat or gluten sensitivity, but these are distinct clinical categories with different evidential problems.
The internet frequently collapses them into one proposition:
That chain is far stronger than the evidence.
The distinction between
and
is exactly why population definition matters.
A mechanism demonstrated in a susceptible disease population cannot simply be transported to everyone else.
Myth 6: “gut-healing foods” have proven universal barrier-restoring effects
Nutrition can affect intestinal barrier function.
That statement is supported.
The stronger claim is that there exists one universal “gut healing diet”.
A 2024 systematic review examined whether dietary interventions alter intestinal barrier permeability in healthy people.
Only 12 studies met inclusion criteria.
Some evidence suggested effects from inulin and probiotics, but the literature was small and heterogeneous.
That is a long way from proving that everyone needs:
- bone broth;
- fermented foods;
- collagen;
- elimination diets;
- low-lectin diets;
- gluten-free diets;
- expensive “gut repair” powders.
The correct conclusion is not that diet has no effect.
It is that
does not imply
Source:
Myth 7: probiotics “seal” a leaky gut
This one is more nuanced because there is real evidence of effects on barrier-related markers.
A 2023 systematic review and meta-analysis of randomized trials reported improvements in several intestinal-barrier-related measures with probiotics.
A 2025 meta-analysis of probiotics, synbiotics and prebiotics also found changes in markers such as lipopolysaccharide-related measures and commercially measured zonulin.
However, two cautions matter.
First, the evidence is heterogeneous.
Different strains are different interventions.
Different populations have different diseases.
Different studies use different permeability measures.
Second, improvement in a barrier biomarker is not automatically equivalent to improvement in the clinical outcome a consumer cares about.
The causal question remains:
Evidence for the first arrow does not automatically establish the second.
And if an outcome relies heavily on a commercial zonulin assay with known analytical problems, interpretation requires additional caution.
Sources:
- Zheng et al., 2023, probiotic meta-analysis
- Ghorbani et al., 2025, prebiotic/probiotic meta-analysis
Myth 8: glutamine repairs everyone’s gut barrier
Glutamine is a biologically plausible candidate.
Enterocytes use glutamine as a metabolic substrate.
That creates a good mechanism.
But a good mechanism does not guarantee a large universal clinical effect.
A 2024 systematic review and meta-analysis of randomized placebo-controlled trials included 10 studies with 352 participants.
Overall, glutamine supplementation did not significantly change intestinal permeability.
Some subgroup analyses suggested effects at higher doses and shorter durations, but the populations were heterogeneous and the authors called for further research.
That is a familiar pattern:
Source:
Myth 9: bloating means the intestinal barrier is damaged
Bloating can occur because of:
- gas production;
- altered motility;
- visceral hypersensitivity;
- constipation;
- fermentation;
- meal volume;
- pelvic-floor dysfunction;
- functional gastrointestinal disorders;
- other gastrointestinal diseases.
It is a sensation and physical phenomenon.
It is not a direct assay of epithelial permeability.
This distinction sounds obvious, but social-media diagnostic trees often do exactly the opposite.
A symptom is treated as evidence of the proposed mechanism.
Then the proposed mechanism is used to explain the symptom.
That is circular reasoning:
No independent measurement enters the model.
Myth 10: “toxins” pass through the gut and create systemic disease
A disrupted intestinal barrier can permit greater translocation of microbial products and other luminal material.
That is biologically plausible and actively researched.
Lipopolysaccharide, or LPS, is frequently invoked in metabolic-inflammation research.
But social media usually replaces specific molecules with the word toxins.
That change matters.
A scientific hypothesis might be:
increased intestinal permeability increases circulating exposure to bacterial products under defined conditions.
The wellness version is:
your gut leaks toxins into your bloodstream.
The second claim is much harder to evaluate because the toxicant is undefined.
To make it testable we need:
“Gut toxins” without those variables is rhetoric.
The microbiome does not turn every gut hypothesis into a proven one
The microbiome is central to intestinal biology.
It affects fermentation, immune development, mucus, metabolite production and host physiology.
It is also one of the easiest scientific fields to overinterpret.
A microbiome study may show that bacterial composition differs between two groups.
That does not immediately tell us:
- whether the difference caused the disease;
- whether the disease caused the difference;
- whether medication caused both;
- whether diet caused both;
- whether changing those bacteria improves outcomes.
The same causal ambiguity appears again:
does not identify direction.
Adding the word microbiome to a leaky-gut story makes it sound modern.
It does not solve causality.
Why the model is commercially powerful
“Leaky gut” is almost ideal for wellness marketing because it creates an invisible problem with no simple reference standard.
The consumer cannot see the barrier.
Symptoms are non-specific.
The proposed biomarkers are debatable.
Recovery has no universally accepted endpoint.
This creates a potentially endless intervention loop:
- test;
- remove foods;
- buy supplements;
- repeat symptoms;
- retest;
- identify another trigger;
- add another intervention.
The model is difficult to falsify because treatment failure can be reinterpreted as evidence of more severe dysfunction.
Scientifically, that is a problem.
Commercially, it is extremely robust.
The zonulin story is a warning about precision theatre
One of the most important lessons here has nothing specifically to do with gastroenterology.
A laboratory number looks objective.
A numerical result such as
feels more scientific than
I feel bloated.
But the authority of a number depends on the measurement chain.
We need:
If the first or second step fails, decimal precision downstream does not rescue the result.
This is precision theatre:
high numerical precision attached to low inferential certainty.
Commercial zonulin testing is an unusually clean example.
Real barrier science is more interesting than the myth
The irony is that the actual science of the intestinal barrier is more interesting than “heal your leaky gut”.
Researchers are studying:
- junctional proteins;
- mucosal immunology;
- host-microbiome signalling;
- epithelial metabolism;
- inflammatory feedback;
- epithelial restitution;
- drug effects;
- exercise and heat stress;
- diet and microbial metabolites;
- disease-specific therapeutic targets.
A 2024 review of intestinal junctional complexes describes the barrier as a highly regulated system influenced by internal and external factors.
A 2024 review of leaky-gut research similarly emphasises both the importance of barrier dysfunction and the continuing lack of consensus about optimal measurement and clinical treatment.
That is how an active scientific field normally looks.
Important.
Promising.
Complicated.
Not solved by one powder.
Sources:
A better framework
When someone claims you have “leaky gut”, ask five questions.
1. What exactly is being measured?
Symptoms are not direct permeability measurements.
2. Which part of the gastrointestinal tract?
Small-intestinal and colonic permeability are not necessarily interchangeable.
3. Which test?
Sugar probes, tissue assays, biomarkers and commercial ELISAs measure different things.
4. What disease or exposure is hypothesised?
Coeliac disease, Crohn's disease, NSAID exposure and endurance exercise are not the same biological state.
5. Does changing the permeability measure improve the outcome that matters?
This is the most important question.
If an intervention lowers a marker but does not improve symptoms, disease activity, complications or quality of life, the clinical meaning remains uncertain.
A useful hierarchy of claims
The subject becomes much clearer if we separate levels of evidence.
| Claim | Evidential burden |
|---|---|
| The intestinal barrier exists | Basic physiology |
| Permeability can change | Human physiological measurement |
| Disease X is associated with altered permeability | Observational/clinical evidence |
| Altered permeability contributes causally to disease X | Mechanistic + longitudinal/interventional evidence |
| Biomarker Z accurately measures permeability | Analytical validation |
| Supplement S improves biomarker Z | Randomized intervention evidence |
| Supplement S improves disease X by repairing permeability | Clinical-outcome + mediation evidence |
Social-media communication often jumps from row 1 to row 7.
The missing rows are where science happens.
What the evidence supports
A defensible summary is straightforward.
Intestinal permeability is real.
The gut barrier is dynamic rather than simply open or closed.
Barrier dysfunction occurs in defined diseases such as coeliac disease and inflammatory bowel disease.
Stressors including intense exercise and some medications can transiently alter permeability.
Several dietary and microbial interventions may influence barrier-related measures, but results are population-specific and heterogeneous.
Commercial serum zonulin assays have serious validity problems and should not be treated as simple definitive “leaky gut tests”.
There is no validated universal syndrome in which a single gut-barrier defect explains every combination of fatigue, brain fog, bloating, skin problems, autoimmunity and weight gain.
And most importantly:
Conclusion
“Leaky gut” is a perfect example of how social-media health myths evolve.
Start with a real biological process.
Give it a vivid name.
Connect it to a broad list of symptoms.
Introduce an imperfect biomarker.
Then sell a universal solution.
The scientific literature tells a much more interesting story.
The intestinal barrier is dynamic, tissue-specific and measurable only imperfectly.
Its dysfunction is important in several diseases.
It may participate causally in some disease mechanisms.
But there is no evidence that one universal “leaky gut syndrome” explains the enormous collection of symptoms attributed to it online.
A useful rule is:
The gut can become more permeable.
That does not mean every tired person needs to “heal” it.
References
-
Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516–1526. https://pubmed.ncbi.nlm.nih.gov/31076401/
-
Cummins AG, Penttila IA, Labrooy JT, Robb TA, Davidson GP. Recovery of the small intestine in coeliac disease on a gluten-free diet: changes in intestinal permeability, small bowel morphology and T-cell activity. 1991. https://pubmed.ncbi.nlm.nih.gov/1883978/
-
Rath T, Atreya R, Neurath MF. A spotlight on intestinal permeability and inflammatory bowel diseases. Expert Review of Gastroenterology & Hepatology. 2023;17:893–902. https://pubmed.ncbi.nlm.nih.gov/37606514/
-
Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics. 2023. https://pubmed.ncbi.nlm.nih.gov/37773554/
-
Ajamian M, Steer D, Rosella G, Gibson PR. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One. 2019. https://pubmed.ncbi.nlm.nih.gov/30640940/
-
Scheffler L, Crane A, Heyne H, et al. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Frontiers in Endocrinology. 2018;9:22. https://pubmed.ncbi.nlm.nih.gov/29459849/
-
Power N, Turpin W, Espin-Garcia O, et al. Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients. Frontiers in Physiology. 2021;12:645303. https://pubmed.ncbi.nlm.nih.gov/33841181/
-
Tatucu-Babet OA, Forsyth A, Owen E, et al. Serum zonulin measured by enzyme-linked immunosorbent assay may not be a reliable marker of small intestinal permeability in healthy adults. Nutrition Research. 2020;78:82–92. https://pubmed.ncbi.nlm.nih.gov/32563954/
-
Biomarkers in body fluids and their detection techniques for human intestinal permeability assessment. 2025. https://pubmed.ncbi.nlm.nih.gov/40793775/
-
Costa RJS, et al. The Effects of Exercise on Indirect Markers of Gut Damage and Permeability: A Systematic Review and Meta-analysis. 2020. https://pubmed.ncbi.nlm.nih.gov/33201454/
-
Nascimento DSM, et al. Can Diet Alter the Intestinal Barrier Permeability in Healthy People? A Systematic Review. Nutrients. 2024. https://pubmed.ncbi.nlm.nih.gov/38931225/
-
Zheng Y, Zhang Z, Tang P, et al. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Frontiers in Immunology. 2023. https://pubmed.ncbi.nlm.nih.gov/37168869/
-
Ghorbani Z, et al. Reinforcing gut integrity: A systematic review and meta-analysis of clinical trials assessing probiotics, synbiotics, and prebiotics on intestinal permeability markers. Pharmacological Research. 2025;216:107780. https://pubmed.ncbi.nlm.nih.gov/40378939/
-
Abbasi F, et al. A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults. Amino Acids. 2024;56:60. https://pubmed.ncbi.nlm.nih.gov/39397201/
-
Camilleri M. Human Intestinal Barrier: Effects of Stressors, Diet, Prebiotics, and Probiotics. Clinical and Translational Gastroenterology. 2021;12:e00308. https://pubmed.ncbi.nlm.nih.gov/33492118/
-
Deciphering internal and external factors influencing intestinal junctional complexes. 2024. https://pubmed.ncbi.nlm.nih.gov/39150987/
-
The Leaky Gut and Human Diseases: “Can't Fill the Cup if You Don't Plug the Holes First”. 2024. https://pubmed.ncbi.nlm.nih.gov/39047703/
-
Recent advances in measuring the effects of diet on gastrointestinal physiology: Probing the “leaky gut”. 2024. https://pubmed.ncbi.nlm.nih.gov/38957479/
This article discusses intestinal-barrier physiology and population-level evidence. Persistent gastrointestinal symptoms, unexplained weight loss, bleeding, anaemia, fever or suspected coeliac or inflammatory bowel disease require clinical assessment rather than a commercial “gut-healing” protocol.
Embed interactive plots, widgets, and demos using <figure>, <iframe>, or <div class="interactive-embed"> containers. Ensure each embed includes descriptive captions for accessibility.
How to cite
Use the quick export buttons to save citations for reference managers or copy the formatted text directly.
Diogo Ribeiro (2026). “Leaky Gut” Is Not One Disease: What Social Media Gets Wrong About Intestinal Permeability. Faculty of Media Arts and Design, Technical University of Porto. https://diogoribeiro7.github.io/healthcare/leaky_gut_social_media_myths/.
